The Potential of MicroRNAs in Personalized Medicine against Cancers

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Saumet, Anne ^a   Mathelier, Anthony ^b   Lecellier, Charles Henri ^a,b,c  

^a UNIV MONTPELLIER   (France)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

BIOGENESIS; CANCER DIAGNOSIS; GENE TARGETING; HUMAN; MALIGNANT NEOPLASTIC DISEASE; PERSONALIZED MEDICINE; REVIEW; ANIMAL; DRUG DELIVERY SYSTEM; DRUG DEVELOPMENT; GENETICS; METABOLISM; MOUSE; NEOPLASMS;

ANIMALS; DRUG DELIVERY SYSTEMS; DRUG DISCOVERY; HUMANS; INDIVIDUALIZED MEDICINE; MICE; MICRORNAS; NEOPLASMS;

EID: 84921360532     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/642916     Document Type: Review

References (159)

1. K. Teng and L. S. Acheson, "Genomics in primary care practice, " Primary Care, vol. 41, pp. 421-435, 2014.
2. A. Rafii, C. Touboul, H. AlThani, K. Suhre, and J. A. Malek, "Where cancer genomics should go next: a clinicians perspective, " Human Molecular Genetics, 2014.
3. L. Chin, J. N. Andersen, and P. A. Futreal, "Cancer genomics: from discovery science to personalized medicine, " Nature Medicine, vol. 17, no. 3, pp. 297-303, 2011.
4. E. Dreussi, P. Biason, G. Toffoli, and E. Cecchin, "miRNA pharmacogenomics: the newfrontier for personalizedmedicine in cancer?" Pharmacogenomics, vol. 13, no. 14, pp. 1635-1650, 2012.
5. M. Fabbri, "MicroRNAs and cancer: towards a personalized medicine, " Current Molecular Medicine, vol. 13, no. 5, pp. 751-756, 2013.
6. S. M. Metias, E. Lianidou, and G. M. Yousef, "MicroRNAs in clinical oncology: at the crossroads between promises and problems, " Journal of Clinical Pathology, vol. 62, no. 9, pp. 771-776, 2009.
7. A. Kozomara and S. Griffiths-Jones, "miRBase: annotating high confidence microRNAs using deep sequencing data, " Nucleic Acids Research, vol. 42, pp. D68-D73, 2013.
8. S. L. Ameres and P. D. Zamore, "Diversifying microRNA sequence and function, " Nature ReviewsMolecular Cell Biology, vol. 14, no. 8, pp. 475-488, 2013.
9. D. P. Bartel, "MicroRNAs: target recognition and regulatory functions, " Cell, vol. 136, no. 2, pp. 215-233, 2009.
10. M. Ghildiyal and P. D. Zamore, "Small silencing RNAs: an expanding universe, " Nature Reviews Genetics, vol. 10, no. 2, pp. 94-108, 2009.
11. L. A. Yates, C. J. Norbury, and R. J. C. Gilbert, "The long and short of microRNA, " Cell, vol. 153, no. 3, pp. 516-519, 2013.
12. G. A. Calin, C. D. Dumitru, M. Shimizu, et al., "Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia, " Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 24, pp. 15524-15529, 2002.
13. C. M. Croce, "Causes and consequences of microRNA dysregulation in cancer, " Nature Reviews Genetics, vol. 10, no. 10, pp. 704-714, 2009.
14. M. Esteller, "Non-coding RNAs in human disease, " Nature Reviews Genetics, vol. 12, no. 12, pp. 861-874, 2011.
15. G. A. Calin and C. M. Croce, "MicroRNA signatures in human cancers, " Nature Reviews Cancer, vol. 6, no. 11, pp. 857-866, 2006.
16. M. V. Iorio, M. Ferracin, C.-G. Liu, et al., "MicroRNA gene expression deregulation in human breast cancer, " Cancer Research, vol. 65, no. 16, pp. 7065-7070, 2005.
17. J. Lu, G. Getz, E. A. Miska, et al., "MicroRNA expression profiles classify human cancers, " Nature, vol. 435, no. 7043, pp. 834-838, 2005.
18. S. Volinia, G. A. Calin, C. Liu, et al., "A microRNA expression signature of human solid tumors defines cancer gene targets, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 7, pp. 2257-2261, 2006.
19. A. Gyongyosi, O. Docs, Z. Czimmerer, L. Orosz, and A. Horvath, "Measuring expression levels of small regulatory RNA molecules from body fluids and formalin-fixed, paraffinembedded samples, " Methods Molecular Biology, vol. 1182, pp. 105-119, 2014.
20. J. R. Dijkstra, L. J. M. Mekenkamp, S. Teerenstra, I. de Krijger, and I. D. Nagtegaal, "MicroRNA expression in formalin-fixed paraffin embedded: tissue using real time quantitative PCR: the strengths and pitfalls, " Journal of Cellular and Molecular Medicine, vol. 16, no. 4, pp. 683-690, 2012.
21. X. Chen, Y. Ba, L. Ma, et al., "Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases, " Cell Research, vol. 18, no. 10, pp. 997-1006, 2008.
22. M. A. Cortez, C. Bueso-Ramos, J. Ferdin, G. Lopez-Berestein, A. K. Sood, and G. A. Calin, "MicroRNAs in body fluids-the mix of hormones and biomarkers, " Nature Reviews Clinical Oncology, vol. 8, no. 8, pp. 467-477, 2011.
23. A. Etheridge, I. Lee, L. Hood, D. Galas, and K. Wang, "Extracellular microRNA: a new source of biomarkers, " Mutation Research, vol. 717, no. 1-2, pp. 85-90, 2011.
24. H. M. Heneghan, N. Miller, A. J. Lowery, K. J. Sweeney, J. Newell, and M. J. Kerin, "Circulating microRNAs as novel minimally invasive biomarkers for breast cancer, " Annals of Surgery, vol. 251, no. 3, pp. 499-505, 2010.
25. P. S. Mitchell, R. K. Parkin, E. M. Kroh, et al., "Circulating microRNAs as stable blood-based markers for cancer detection, " Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 30, pp. 10513-10518, 2008.
26. M. Garofalo and C. M. Croce, "MicroRNAs as therapeutic targets in chemoresistance, "Drug ResistanceUpdates, vol. 16, no. 3-5, pp. 47-59, 2013.
27. H. Zhang, L. Yang, Y. Zhu, et al., "Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy, " Prostate, vol. 71, no. 3, pp. 326-331, 2011.
28. H. M. Heneghan, N. Miller, and M. J. Kerin, "MiRNAs as biomarkers and therapeutic targets in cancer, " Current Opinion in Pharmacology, vol. 10, no. 5, pp. 543-550, 2010.
29. N. Hauptman and D. Glavac, "MicroRNAs and long noncoding RNAs: prospects in diagnostics and therapy of cancer, " Radiology and Oncology, vol. 47, pp. 311-318, 2013.
30. W. C. S. Cho, "MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy, " International Journal of Biochemistry and Cell Biology, vol. 42, no. 8, pp. 1273-1281, 2010.
31. R. S. Redis, I. Berindan-Neagoe, V. I. Pop, and G. A. Calin, "Non-coding RNAs as theranostics in human cancers, " Journal of Cellular Biochemistry, vol. 113, no. 5, pp. 1451-1459, 2012.
32. V. N. Kim, J. Han, and M. C. Siomi, "Biogenesis of small RNAs in animals, " Nature Reviews Molecular Cell Biology, vol. 10, no. 2, pp. 126-139, 2009.
33. J. Krol, I. Loedige, and W. Filipowicz, "The widespread regulation of microRNA biogenesis, function and decay, " Nature Reviews Genetics, vol. 11, no. 9, pp. 597-610, 2010.
34. N. Tran and G. Hutvagner, "Biogenesis and the regulation of the maturation of miRNAs, " Essays in Biochemistry, vol. 54, no. 1, pp. 17-28, 2013.
35. M. Ha and V. N. Kim, "Regulation of microRNA biogenesis, " Nature Reviews Molecular Cell Biology, vol. 15, pp. 509-524, 2014.
36. A. M. Denli, B. B. J. Tops, R. H. A. Plasterk, R. F. Ketting, and G. J. Hannon, "Processing of primary microRNAs by the Microprocessor complex, " Nature, vol. 432, no. 7014, pp. 231-235, 2004.
37. Y. Lee, C. Ahn, J. Han, et al., "The nuclear RNase III Drosha initiates microRNA processing, " Nature, vol. 425, no. 6956, pp. 415-419, 2003.
38. J. Han, Y. Lee, K. Yeom, Y. Kim, H. Jin, and V. N. Kim, "The Drosha-DGCR8 complex in primary microRNA processing, " Genes and Development, vol. 18, no. 24, pp. 3016-3027, 2004.
39. M. Xie and J. A. Steitz, "Versatile microRNA biogenesis in animals and their viruses, " RNA Biology, vol. 11, no. 6, 2014.
40. A. Brummer and J. Hausser, "MicroRNA binding sites in the coding region of mRNAs: extending the repertoire of posttranscriptional gene regulation, " BioEssays, vol. 36, no. 6, pp. 617-626, 2014.
41. J. R. Lytle, T. A. Yario, and J. A. Steitz, "Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR, " Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 23, pp. 9667-9672, 2007.
42. JW. Nam, OS. Rissland, D. Koppstein, and et al, "Global analyses of the effect of different cellular contexts on microRNA targeting, " Molecular Cell, vol. 53, pp. 1031-1043, 2014.
43. E. Huntzinger and E. Izaurralde, "Gene silencing by microRNAs: contributions of translational repression and mRNA decay, " Nature Reviews Genetics, vol. 12, no. 2, pp. 99-110, 2011.
44. A. Stroynowska-Czerwinska, A. Fiszer, and W. J. Krzyzosiak, "The panorama of miRNA-mediated mechanisms in mammalian cells, " Cellular and Molecular Life Sciences, vol. 71, pp. 2253-2270, 2014.
45. A. Saumet, G. Vetter, M. Bouttier, et al., "Estrogen and retinoic acid antagonistically regulate several microRNA genes to control aerobic glycolysis in breast cancer cells, " Molecular BioSystems, vol. 8, no. 12, pp. 3242-3253, 2012.
46. K. K. Waltering, K. P. Porkka, S. E. Jalava, et al., "Androgen regulation of micro-RNAs in prostate cancer, " The Prostate, vol. 71, no. 6, pp. 604-614, 2011.
47. W. W. Wang, N. Chatterjee, S. V. Chittur, J. Welsh, and M. P. Tenniswood, "Effects of 1α, 25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells, " Molecular Cancer, vol. 10, article 58, 2011.
48. R. Kulshreshtha, M. Ferracin, S. E. Wojcik, et al., "A microRNA signature of hypoxia, "Molecular and Cellular Biology, vol. 27, no. 5, pp. 1859-1867, 2007.
49. Y. Mao, R. Mohan, S. Zhang, and X. Tang, "MicroRNAs as pharmacological targets in diabetes, " Pharmacological Research, vol. 73, pp. 37-47, 2013.
50. C. Chen, L. Li, H. F. Lodish, and D. P. Bartel, "MicroRNAs modulate hematopoietic lineage differentiation, " Science, vol. 303, no. 5654, pp. 83-86, 2004.
51. C. P. Morgan and T. L. Bale, "Sex differences in microRNA regulation of gene expression: no smoke, just miRs, " Biology of Sex Differences, vol. 3, no. 1, article 22, 2012.
52. S. Sharma and M. Eghbali, "Influence of sex differences on microRNA gene regulation in disease, " Biology of Sex Differences, vol. 5, no. 1, article 3, 2014.
53. N. N. Hooten, K. Abdelmohsen, M. Gorospe, N. Ejiogu, A. B. Zonderman, and M. K. Evans, "microRNA expression patterns reveal differential expression of target genes with age, " PLoS ONE, vol. 5, no. 5, Article ID e10724, 2010.
54. N. Noren Hooten, M. Fitzpatrick, W. H. Wood III, et al., "Agerelated changes in microRNA levels in serum, " Aging (Albany NY), vol. 5, pp. 725-740, 2013.
55. C. Y. Lai, Y. T. Wu, S. L. Yu, et al., "Modulated expression of human peripheral blood microRNAs from infancy to adulthood and its role in aging, " Aging Cell, vol. 13, no. 4, pp. 679-689, 2014.
56. N. Pencheva and S. F. Tavazoie, "Control of metastatic progression by microRNA regulatory networks, " Nature Cell Biology, vol. 15, no. 6, pp. 546-554, 2013.
57. Y. Li, A. Ahmad, D. Kong, B. Bao, and F. H. Sarkar, "Targeting microRNAs for personalized cancer therapy, " Medical Principles and Practice, vol. 22, pp. 415-417, 2013.
58. C. Liu, K. Kelnar, B. Liu, et al., "The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44, " Nature Medicine, vol. 17, no. 2, pp. 211-215, 2011.
59. Q. Huang, K. Gumireddy, M. Schrier, et al., "The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis, " Nature Cell Biology, vol. 10, no. 2, pp. 202-210, 2008.
60. Y. Li, C. Qiu, J. Tu, et al., "HMDDv2. 0:adatabase for experimentally supported human microRNA and disease associations, " Nucleic Acids Research, vol. 42, pp. D1070-D1074, 2013.
61. D. Wang, J. Gu, T. Wang, and Z. Ding, "OncomiRDB: a database for the experimentally verified oncogenic and tumorsuppressive microRNAs, " Bioinformatics, 2014.
62. L. He, J. M. Thomson, M. T. Hemann, et al., "A microRNA polycistron as a potential human oncogene, " Nature, vol. 435, no. 7043, pp. 828-833, 2005.
63. T. C. Chang, E. A. Wentzel, O. A. Kent, et al., "Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis, " Molecular Cell, vol. 26, no. 5, pp. 745-752, 2007.
64. D. G. Johnson, "The paradox of E2F1: oncogene and tumor suppressor gene, " Molecular Carcinogenesis, vol. 27, pp. 151-157, 2000.
65. B. D. Rowland, R. Bernards, and D. S. Peeper, "The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene, " Nature Cell Biology, vol. 7, no. 11, pp. 1074-1082, 2005.
66. J. Liang and G. B. Mills, "AMPK: a contextual oncogene or tumor suppressor?" Cancer Research, vol. 73, no. 10, pp. 2929-2935, 2013.
67. A. Toker and Y. R. Chin, "Akt-ing up on SRPK1: oncogene or tumor suppressor?" Molecular Cell, vol. 54, pp. 329-330, 2014.
68. C. Lobry, P. Oh, M. R. Mansour, A. T. Look, and I. Aifantis, "Notch signaling: switching an oncogene to a tumor suppressor, " Blood, vol. 123, pp. 2451-2459, 2014.
69. N. Felli, L. Fontana, E. Pelosi, et al., "MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation, " Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 50, pp. 18081-18086, 2005.
70. P. Pineau, S. Volinia, K. McJunkin, et al., "miR-221 overexpression contributes to liver tumorigenesis, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 1, pp. 264-269, 2010.
71. M. Fabbri, A. Bottoni, M. Shimizu, et al., "Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of b-cell chronic lymphocytic leukemia, " The Journal of the American Medical Association, vol. 305, no. 1, pp. 59-67, 2011.
72. M. V. Iorio and C. M. Croce, "Causes and consequences of MicroRNA dysregulation, " Cancer Journal, vol. 18, no. 3, pp. 215-222, 2012.
73. P. Lopez-Serra and M. Esteller, "DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer, " Oncogene, vol. 31, no. 13, pp. 1609-1622, 2012.
74. G. A. Calin, C. Sevignani, C. D. Dumitru, et al., "Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers, " Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 9, pp. 2999-3004, 2004.
75. L. Zhang, J. Huang, N. Yang, et al., "microRNAs exhibit high frequency genomic alterations in human cancer, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 24, pp. 9136-9141, 2006.
76. H. Tagawa and M. Seto, "A microRNA cluster as a target of genomic amplification inmalignant lymphoma, " Leukemia, vol. 19, no. 11, pp. 2013-2016, 2005.
77. V. Davalos and M. Esteller, "MicroRNAs and cancer epigenetics: a macrorevolution, " Current Opinion in Oncology, vol. 22, no. 1, pp. 35-45, 2010.
78. Z. Wang, H. Yao, S. Lin, et al., "Transcriptional and epigenetic regulation of humanmicroRNAs, " Cancer Letters, vol. 331, no. 1, pp. 1-10, 2013.
79. A. Saumet, G. Vetter, M. Bouttier, et al., "Transcriptional repression of microRNA genes by PML-RARA increases expression of key cancer proteins in acute promyelocytic leukemia, " Blood, vol. 113, no. 2, pp. 412-421, 2009.
80. S. Hua, R. Kittler, and K. P. White, "Genomic antagonism between retinoic acid and estrogen signaling in breast cancer, " Cell, vol. 137, no. 7, pp. 1259-1271, 2009.
81. S. R. Viswanathan, G. Q. Daley, and R. I. Gregory, "Selective blockade of microRNA processing by Lin28, " Science, vol. 320, no. 5872, pp. 97-100, 2008.
82. C. Blenkiron, L. D. Goldstein, N. P. Thorne, et al., "MicroRNA expression prof iling of human breast cancer identifies new markers of tumor subtype, " Genome Biology, vol. 8, article R214, 2007.
83. K. A. Avery-Kiejda, S. G. Braye, J. F. Forbes, and R. J. Scott, "The expression of Dicer and Drosha inmatched normal tissues, tumours and lymph node metastases in triple negative breast cancer, " BMC Cancer, vol. 14, article 253, 2014.
84. G. Di Leva and C. M. Croce, "MiRNA prof iling of cancer, " Current Opinion in Genetics and Development, vol. 23, no. 1, pp. 3-11, 2013.
85. A. J. Lowery, N. Miller, A. Devaney, et al., "MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer, " Breast Cancer Research, vol. 11, no. 3, article R27, 2009.
86. P. J. Mishra, D. Banerjee, and J. R. Bertino, "MiRSNPs or MiRpolymorphisms, newplayers in microRNAmediated regulation of the cell: introducing microRNA pharmacogenomics, " Cell Cycle, vol. 7, no. 7, pp. 853-858, 2008.
87. D. Landi, F. Gemignani, R. Barale, and S. Landi, "A catalog of polymorphisms falling in microRNA-binding regions of cancer genes, " DNA and Cell Biology, vol. 27, no. 1, pp. 35-43, 2008.
88. R. Duan, C. Pak, and P. Jin, "Single nucleotide polymorphism associated with mature miR-125a alters the processing of primiRNA, " HumanMolecularGenetics, vol. 16, no. 9, pp. 1124-1131, 2007.
89. Z. Hu, J. Chen, T. Tian, et al., "Genetic variants of miRNA sequences and non-small cell lung cancer survival, " Journal of Clinical Investigation, vol. 118, no. 7, pp. 2600-2608, 2008.
90. Z. Hu, J. Liang, Z. Wang, et al., "Commongenetic variants inpremicroRNAs were associated with increased risk of breast cancer in Chinese women, " Human Mutation, vol. 30, no. 1, pp. 79-84, 2009.
91. B. P. Lewis, C. B. Burge, and D. P. Bartel, "Conserved seed pairing, of ten flanked by adenosines, indicates that thousand s of human genes are microRNA targets, " Cell, vol. 120, no. 1, pp. 15-20, 2005.
92. A. E. Bruno, L. Li, J. L. Kalabus, Y. Pan, A. Yu, and Z. Hu, "miRdSNP: A database of disease-associated SNPs and microRNA target sites on 3UTRs of human genes, " BMC Genomics, vol. 13, no. 1, article 44, 2012.
93. A. Bhattacharya, J. D. Ziebarth, and Y. Cui, "SomamiR: a database for somatic mutations impacting microRNA function in cancer, " Nucleic Acids Research, vol. 41, no. D1, pp. D977-D982, 2012.
94. M. P. Hamilton, K. Rajapakshe, S. M. Hartig, et al., "Identification of a pan-cancer oncogenic microRNA superfamily anchored by a central core seed motif, " Nature Communications, vol. 4, article 2730, 2013.
95. R. Sabarinathan, A. Wenzel, P. Novotny, et al., "Transcriptomewide analysis of UTRs in non-small cell lung cancer reveals cancer-related genes with SNV-induced changes on RNA secondary structure and miRNA target sites, " PLoS ONE, vol. 9, Article ID e82699, 2014.
96. C. Chen, D. A. Ridzon, A. J. Broomer, et al., "Real-time quantification of microRNAs by stem-loop RT-PCR, " Nucleic Acids Research, vol. 33, no. 20, article e179, 2005.
97. M. R. Friedlander, E. Lizano, A. J. Houben, et al., "Evidence for the biogenesis of more than 1, 000 novel human microRNAs, " Genome Biology, vol. 15, article R57, 2014.
98. A. Kozomara and S. Griffiths-Jones, "MiRBase: integrating microRNA annotation and deep-sequencing data, " Nucleic Acids Research, vol. 39, no. 1, pp. D152-D157, 2011.
99. W. Zhou, M. Y. Fong, Y. Min, G. Somlo, and L. Liu, "Cancersecreted miR-105 destroys vascular endothelial barriers to promote metastasis, " Cancer Cell, vol. 25, pp. 501-515, 2014.
100. R. M. Drayton, E. Dudziec, S. Peter, S. Bertz, and A. Hartmann, "Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine/glutamate exchanger SLC7A11, " Clinical Cancer Research, vol. 20, pp. 1990-2000, 2014.
101. H. Wu, Z. Xiao, H. Zhang, K. Wang, W. Liu, and Q. Hao, "MiR modulates cisplatin resistance in human ovarian cancer cells by targeting Akt3, " Anticancer Drugs, vol. 25, no. 7, pp. 799-809, 2014.
102. M. Yang, X. Shan, X. Zhou, T. Qiu, and W. Zhu, "miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2, " Anti-Cancer Agents in Medicinal Chemistry, vol. 14, no. 6, pp. 884-891, 2014.
103. M. Fabbri, A. Paone, F. Calore, et al., "MicroRNAs bind to Tolllike receptors to induce prometastatic inflammatory response, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 31, pp. E2110-E2116, 2012.
104. J. R. Chevillet, I. Lee, H. A. Briggs, Y. He, and K. Wang, "Issues and prospects of microRNA-based biomarkers in blood and other body fluids, " Molecules, vol. 19, pp. 6080-6105, 2014.
105. J. D. Arroyo, J. R. Chevillet, E. M. Kroh, et al., "Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma, " Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 12, pp. 5003-5008, 2011.
106. H. Valadi, K. Ekstrom, A. Bossios, M. Sjostrand, J. J. Lee, and J. O. Lotvall, "Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells, " Nature Cell Biology, vol. 9, no. 6, pp. 654-659, 2007.
107. K. C. Vickers, B. T. Palmisano, B. M. Shoucri, R. D. Shamburek, and A. T. Remaley, "MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins, " Nature Cell Biology, vol. 13, no. 4, pp. 423-435, 2011.
108. A. Ruepp, A. Kowarsch, and F. Theis, "PhenomiR: microRNAs in human diseases and biological processes, " MethodsMolecular Biology, vol. 822, pp. 249-260, 2011.
109. C. P. Goswami and H. Nakshatri, "PROGmiR: a tool for identifying prognostic miRNA biomarkers in multiple cancers using publicly available data, " Journal of Clinical Bioinformatics, vol. 2, no. 1, article 23, 2013.
110. A. Lagana, S. Forte, A. Giudice, et al., miRo: A miRNA Knowledge Base. Database, Oxford, UK, 2009.
111. F. Russo, S. Di Bella, G. Nigita, et al., "miRandola: extracellular circulating microRNAs database, " PLoS ONE, vol. 7, no. 10, Article ID e47786, 2012.
112. J. Jarry, D. Schadendorf, C. Greenwood, A. Spatz, and L. C. van Kempen, "The validity of circulating microRNAs in oncology: five years of challenges and contradictions, " Molecular Oncology, vol. 8, no. 4, pp. 819-829, 2014.
113. R. S. Leidner, L. Li, and C. L. Thompson, "Dampening enthusiasmfor circulatingmicroRNA in breast cancer, " PLoS ONE, vol. 8, no. 3, Article ID e57841, 2013.
114. N. Becker and C. M. Lockwood, "Pre-analytical variables in miRNA analysis, " Clinical Biochemistry, vol. 46, no. 10-11, pp. 861-868, 2013.
115. K. W. Witwer, "Data submission and quality in microarraybased MicroRNA prof iling, " Clinical Chemistry, vol. 59, no. 2, pp. 392-400, 2013.
116. C. C. Pritchard, H. H. Cheng, and M. Tewari, "MicroRNA prof iling: approaches and considerations, " Nature Reviews Genetics, vol. 13, no. 5, pp. 358-369, 2012.
117. K. Wang, Y. Yuan, J. Cho, S. McClarty, D. Baxter, and D. J. Galas, "Comparing the MicroRNA spectrum between serum and plasma, " PLoS ONE, vol. 7, no. 7, Article ID e41561, 2012.
118. H. H. Cheng, H. S. Yi, Y. Kim, et al., "Plasma processing conditions substantially influence circulating microRNA biomarker levels, " PLoS ONE, vol. 8, no. 6, Article ID e64795, 2013.
119. T. Blondal, S. J. Nielsen, A. Baker, et al., "Assessing sample and miRNA profile quality in serum and plasma or other biof luids, " Methods, vol. 59, no. 1, pp. S1-S6, 2013.
120. M. B. Kirschner, S. C. Kao, J. J. Edelman, et al., "Haemolysis during sample preparation altersmicroRNAcontent of plasma, " PLoS ONE, vol. 6, no. 9, Article ID e24145, 2011.
121. C. C. Pritchard, E. Kroh, B. Wood, et al., "Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies, " Cancer Prevention Research, vol. 5, no. 3, pp. 492-497, 2012.
122. M. B. Kirschner, J. J. Edelman, S. C. Kao, et al., "The impact of hemolysis on cell-free microRNA biomarkers, " Frontiers in Genetics, vol. 4, article 94, 2013.
123. G. Tzimagiorgis, E. Z. Michailidou, A. Kritis, A. K. Markopoulos, and S. Kouidou, "Recovering circulating extracellular or cell-free RNA from bodily fluids, " Cancer Epidemiology, vol. 35, no. 6, pp. 580-589, 2011.
124. E. M. Kroh, R. K. Parkin, P. S. Mitchell, and M. Tewari, "Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRTPCR), " Methods, vol. 50, no. 4, pp. 298-301, 2010.
125. Y. Kim, J. Yeo, B. Kim, M. Ha, and V. N. Kim, "Short structured RNAs with lowGC content are selectively lost during extraction from a small number of cells, " Molecular Cell, vol. 46, no. 6, pp. 893-895, 2012.
126. M. Monleau, S. Bonnel, T. Gostan, et al., "Comparison of different extraction techniques to profile microRNAs from human sera and peripheral blood mononuclear cells, " BMC Genomics, vol. 15, article 395, 2014.
127. G. S. Mack, "MicroRNA gets down to business, " Nature Biotechnology, vol. 25, no. 6, pp. 631-638, 2007.
128. G. Manceau, S. Imbeaud, R. Thiebaut, F. Liebaert, and K. Fontaine, "Hsa-miR-31-3p expression is linked to progressionfree survival in patients with KRAS wild-type metastatic colorectal cancer treated with anti-EGFR therapy, " Clinical Cancer Research, 2014.
129. A. G. Seto, "The road toward microRNA therapeutics, " The International Journal of Biochemistry & Cell Biology, vol. 42, no. 8, pp. 1298-1305, 2010.
130. R. Garzon, G. Marcucci, and C. M. Croce, "Targeting microRNAs in cancer: rationale, strategies and challenges, " Nature Reviews Drug Discovery, vol. 9, no. 10, pp. 775-789, 2010.
131. J. A. Broderick and P. D. Zamore, "MicroRNA therapeutics, " GeneTherapy, vol. 18, no. 12, pp. 1104-1110, 2011.
132. D. Nalls, S. N. Tang, M. Rodova, R. K. Srivastava, and S. Shankar, "Targeting epigenetic regulation of mir-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells, " PLoS ONE, vol. 6, no. 8, Article ID e24099, 2011.
133. Y. Saito and P. A. Jones, "Epigenetic activation of tumor suppressor microRNAs in human cancer cells, " Cell Cycle, vol. 5, no. 19, pp. 2220-2222, 2006.
134. J.-J. Zhao, J. Lin, H. Yang, et al., "MicroRNA-221/222 negatively regulates estrogen receptor α and is associated with tamoxifen resistance in breast cancer, " The Journal of Biological Chemistry, vol. 283, no. 45, pp. 31079-31086, 2008.
135. C. Rolfo, D. Fanale, D. S. Hong, et al., "Impact of microRNAs in resistance to chemotherapy and novel targeted agents in nonsmall cell lung cancer, " Current Pharmaceutical Biotechnology, 2014.
136. D. R. Cochrane, N. S. Spoelstra, E. N. Howe, S. K. Nordeen, and J. K. Richer, "MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents, " Molecular Cancer Therapeutics, vol. 8, no. 5, pp. 1055-1066, 2009.
137. K. A. Lennox and M. A. Behlke, "Chemical modification and design of anti-miRNA oligonucleotides, " GeneTherapy, vol. 18, no. 12, pp. 1111-1120, 2011.
138. J. Stenvang, A. N. Silahtaroglu, M. Lindow, J. Elmen, and S. Kauppinen, "The utility of LNA in microRNA-based cancer diagnostics and therapeutics, " Seminars in Cancer Biology, vol. 18, no. 2, pp. 89-102, 2008.
139. S. Obad, C. O. dosSantos, A. Petri, et al., "Silencingof microRNA families by seed-targeting tiny LNAs, " Nature Genetics, vol. 43, no. 4, pp. 371-378, 2011.
140. J. Krutzfeldt, N. Rajewsky, R. Braich, et al., "Silencing of microRNAs in vivo with "antagomirs", " Nature, vol. 438, no. 7068, pp. 685-689, 2005.
141. J. Elmen, M. Lindow, S. Schutz, et al., "LNA-mediated microRNA silencing in non-human primates, " Nature, vol. 452, no. 7189, pp. 896-899, 2008.
142. M. Lindow and S. Kauppinen, "Discovering the first micrornatargeted drug, " Journal of Cell Biology, vol. 199, no. 3, pp. 407-412, 2012.
143. M. S. Ebert and P. A. Sharp, "MicroRNAsponges: progress and possibilities, " RNA, vol. 16, no. 11, pp. 2043-2050, 2010.
144. M. S. Ebert, J. R. Neilson, and P. A. Sharp, "MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells, " Nature Methods, vol. 4, no. 9, pp. 721-726, 2007.
145. J. Kluiver, J. H. Gibcus, C. Hettinga, et al., "Rapid generation of microRNA sponges for microRNA inhibition, " PLoS ONE, vol. 7, no. 1, Article ID e29275, 2012.
146. Y. Tay, J. Rinn, and P. P. Pand olfi, "The multilayered complexity of ceRNA crosstalk and competition, " Nature, vol. 505, pp. 344-352, 2014.
147. R. Denzler, V. Agarwal, J. Stefano, D. P. Bartel, and M. Stoffel, "Assessing the ceRNA hypothesis with quantitative measurements of miRNA and target abundance, "Molecular Cell, vol. 54, no. 5, pp. 766-776, 2014.
148. D. Cazalla, T. Yario, and J. A. Steitz, "Down-regulation of a host MicroRNA by a Herpesvirus saimiri noncoding RNA, " Science, vol. 328, no. 5985, pp. 1563-1566, 2010.
149. D. D. Vo, C. Staedel, L. Zehnacker, et al., "Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules, " ACS Chemical Biology, vol. 9, pp. 711-721, 2013.
150. J. C. Henry, A. C. P. Azevedo-Pouly, and T. D. Schmittgen, "MicroRNA replacement therapy for cancer, " Pharmaceutical Research, vol. 28, no. 12, pp. 3030-3042, 2011.
151. V. J. Craig, A. Tzankov, M. Flori, C. A. Schmid, A. G. BaDer, and A. Muller, "Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo, " Leukemia, vol. 26, no. 11, pp. 2421-2424, 2012.
152. M. Agostini and R. A. Knight, "miR-34: frombench to bedside, " Oncotarget, vol. 5, pp. 872-881, 2014.
153. A. G. Bader, "MiR-34-a microRNA replacement therapy is headed to the clinic, " Frontiers in Genetics, vol. 3, article 120, 2012.
154. Q. L. Hu, Q. Y. Jiang, X. Jin, et al., "Cationic microRNAdelivering nanovectors with bifunctional peptides for efficient treatment of PANC-1 xenograft model, " Biomaterials, vol. 34, no. 9, pp. 2265-2276, 2013.
155. J. D. Palmer, B. P. Soule, B. A. Simone, N. G. Zaorsky, L. Jin, and N. L. Simone, "MicroRNA expression altered by diet: can food be medicinal?" Ageing Research Reviews, 2014.
156. L. Garcia-Segura, M. Perez-Andrade, J. Miranda-Rios, and C. Piso, "The emerging role of MicroRNAs in the regulation of gene expression by nutrients, " Journal of Nutrigenetics and Nutrigenomics, vol. 6, no. 1, pp. 16-31, 2013.
157. C. C. Dahm, R. H. Keogh, E. A. Spencer, et al., "Dietary fiber and colorectal cancer risk: a nested case-control study using food diaries, " Journal of the National Cancer Institute, vol. 102, no. 9, pp. 614-626, 2010.
158. S. Hu, T. S. Dong, S. R. Dalal, et al., "The microbe-derived short chain fatty acid butyrate targets miRNA-dependent p21 gene expression in human colon Cancer, " PLoS ONE, vol. 6, no. 1, Article ID e16221, 2011.
159. T. R. Cech and J. A. Steitz, "The noncoding RNA revolutiontrashing old rules to forge new ones, " Cell, vol. 157, pp. 77-94, 2014.